Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease☆

[1]  O. Hornykiewicz,et al.  Globus pallidus dopamine and Parkinson motor subtypes , 2008, Neurology.

[2]  Regina Katzenschlager,et al.  Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.

[3]  Moussa B. H. Youdim,et al.  Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity , 2010, Progress in Neurobiology.

[4]  I. McKeith,et al.  Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[6]  E. Oberhauser,et al.  Iron concentratio n bal ganglia and cerebral cortex obtained by overloading rabbits and monkeys with iron dextran. , 1970, Journal of neurosurgery.

[7]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[8]  Richard S. Frackowiak,et al.  Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps , 2009, NeuroImage.

[9]  Marguerite Wieler,et al.  Midbrain iron content in early Parkinson disease , 2008, Neurology.

[10]  Klaus Seppi,et al.  An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism , 2005, Current opinion in neurology.

[11]  J. Missimer,et al.  Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. , 1995, Archives of neurology.

[12]  B. Bergamasco,et al.  Modifications of the iron–neuromelanin system in Parkinson's disease , 2006, Journal of neurochemistry.

[13]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[14]  J. Connor,et al.  Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.

[15]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[16]  Ronald J. Faber,et al.  Compulsive buying: descriptive characteristics and psychiatric comorbidity. , 1994, The Journal of clinical psychiatry.

[17]  Mircea Ariel Schoenfeld,et al.  Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging , 2004, NeuroImage.

[18]  S. Chung,et al.  Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease , 2008, Movement Disorders.

[19]  Richard S. Frackowiak,et al.  Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ) , 2011, NeuroImage.

[20]  J. Jankovic,et al.  Functional decline in Parkinson disease. , 2001, Archives of neurology.

[21]  Beate Ritz,et al.  Clinical characteristics in early Parkinson's disease in a central California population‐based study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[22]  Robin K. Henson,et al.  The Use and Impact of Adjusted R 2 Effects in Published Regression Research , 2007 .

[23]  D. Koziorowski,et al.  Iron as a cause of Parkinson disease - a myth or a well established hypothesis? , 2009, Parkinsonism & related disorders.

[24]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[25]  T Revesz,et al.  A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.

[26]  Hans-Jochen Heinze,et al.  Mesolimbic novelty processing in older adults. , 2007, Cerebral cortex.

[27]  M. Farrer,et al.  Missing pieces in the Parkinson's disease puzzle , 2010, Nature Medicine.

[28]  Anders M. Dale,et al.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.

[29]  D. Aarsland,et al.  Changes in motor subtype and risk for incident dementia in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[30]  Peter Riederer,et al.  The relevance of iron in the pathogenesis of Parkinson’s disease , 2011, Journal of neurochemistry.

[31]  K. Jellinger,et al.  The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease , 1991, Journal of neuropathology and experimental neurology.

[32]  Junxia Xie,et al.  Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease , 2011, Journal of Neural Transmission.